ZBP1 and Crohn's colitis: This study elucidates a pathogenic pathway in which ITLN1 competitively binds TRIM8 to inhibit CAPN2 ubiquitination and degradation, stabilizing CAPN2 to promote ZBP1-mediated PANoptosis in IECs and exacerbate Crohn's colitis.